Elanco Animal Health Inc (NYSE:ELAN) has a beta value of 1.40 and has seen 2.51 million shares traded in the recent trading session. The company, currently valued at $6.67B, closed the recent trade at $13.49 per share which meant it lost -$0.46 on the day or -3.30% during that session. The ELAN stock price is -39.36% off its 52-week high price of $18.80 and 36.84% above the 52-week low of $8.52. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.98 million shares traded. The 3-month trading volume is 4.79 million shares.
The consensus among analysts is that Elanco Animal Health Inc (ELAN) is Buy stock at the moment, with a recommendation rating of 1.86. 1 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 5 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.12.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Elanco Animal Health Inc (NYSE:ELAN) trade information
Sporting -3.30% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the ELAN stock price touched $13.49 or saw a rise of 8.6%. Year-to-date, Elanco Animal Health Inc shares have moved -9.47%, while the 5-day performance has seen it change -7.54%. Over the past 30 days, the shares of Elanco Animal Health Inc (NYSE:ELAN) have changed -5.60%. Short interest in the company has seen 12.42 million shares shorted with days to cover at 2.43.
Wall Street analysts have a consensus price target for the stock at $27, which means that the shares’ value could jump 50.04% from the levels at last check today. The projected low price target is $16.0 while the price target rests at a high of $37.0. In that case, then, we find that the latest price level in today’s session is -174.28% off the targeted high while a plunge would see the stock gain -18.61% from the levels at last check today.
Elanco Animal Health Inc (ELAN) estimates and forecasts
Figures show that Elanco Animal Health Inc shares have underperformed across the wider relevant industry. The company’s shares have gained 0.59% over the past 6 months, with this year growth rate of 3.37%, compared to 17.20% for the industry. Revenue growth from the last financial year stood is estimated to be 0.30%.
9 analysts offering their estimates for the company have set an average revenue estimate of 1.03B for the current quarter. 9 have an estimated revenue figure of 1.01B for the next ending quarter.
Earnings growth for 2024 is a modest 3.32% while over the next 5 years, the company’s earnings are expected to increase by 10.47%.
ELAN Dividends
Elanco Animal Health Inc is expected to release its next earnings report on 2024-Nov-07 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Elanco Animal Health Inc (NYSE:ELAN)’s Major holders
Insiders own 0.66% of the company shares, while shares held by institutions stand at 99.13% with a share float percentage of 99.79%. Investors are also buoyed by the number of investors in a company, with Elanco Animal Health Inc having a total of 541.0 institutions that hold shares in the company. The top two institutional holders are DODGE & COX with over 83.58 million shares worth more than $1.21 billion. As of 2024-06-30, DODGE & COX held 16.9471% of shares outstanding.
The other major institutional holder is PRIMECAP MANAGEMENT CO/CA/, with the holding of over 52.8 million shares as of 2024-06-30. The firm’s total holdings are worth over $761.94 million and represent 10.7062% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Dodge & Cox Stock Fund and Vanguard/Primecap Fund. As of Jun 30, 2024, the former fund manager holds about 11.21% shares in the company for having 55.4 shares of worth $743.7 million while later fund manager owns 19.02 shares of worth $255.3 million as of Jun 30, 2024, which makes it owner of about 3.85% of company’s outstanding stock.
